Curebase's decentralized clinical trial model ensures more diverse studies because unique populations – which typically are underrepresented in clinical trials – can be included. The company's virtual research sites also provide physicians with new and unique options to offer their patients, regardless of location. The Curebase platform empowers sponsors, CROs and physicians from practices of all sizes to conduct clinical research, including private practices, independent clinics, and large academic research sites.
DTA membership has grown more than 60% since the beginning of 2021, fueled by the organization's leadership role in accelerating the adoption of clinically proven DTx products into the market. As members complete clinical trials, receive regulatory clearance, and enter new markets, DTA's Resource Partner Program will support the burgeoning industry during these critical steps.
Ad Statistics
Times Displayed: 50201
Times Visited: 1423 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"Our partnership with Curebase was driven by growing demand among our members for support in launching and successfully completing clinical trials," said Andy Molnar, chief executive officer of the Digital Therapeutics Alliance. "As a leader in the clinical trial space, Curebase will provide in-depth support for DTA members to help them more quickly develop and get their products into the hands of patients who need them."
Curebase and DTA expect to publish the white paper for DTA members in April of 2022.
About Curebase
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies. We are proving that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities where they live. By applying cutting edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up. For more information, please visit www.curebase.com.
About DTA
The Digital Therapeutics Alliance (DTA) is a global non-profit trade association of industry leaders and stakeholders with the mission of broadening the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. To learn more, please visit: www.dtxalliance.org or follow us on LinkedIn and Twitter.
Back to HCB News
